Koukouvinou suggests the real problem is with pharmaceutical companies and doctors that she says conspire to keep high-price brand names being prescribed, and not generics.
Kukuvinu ukazuje da je pravi problem to što farmaceutske kompanije i doktori sarađuju kako bi se prepisivali brendirani skupi lekovi, a ne generički.